Shi, Yu <br/><br/>
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring.  [electronic resource] 

 -  Nature  05 2019 
 - 131-135 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4687 
<br/><br/><label>Standard No.: </label>10.1038/s41586-019-1130-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Carcinogenesis--genetics<br/>Carcinoma, Pancreatic Ductal--diagnosis<br/>Cell Differentiation--drug effects<br/>Cell Line, Tumor<br/>Disease Progression<br/>Drug Resistance, Neoplasm<br/>Epithelial-Mesenchymal Transition<br/>Female<br/>Humans<br/>Leukemia Inhibitory Factor--antagonists & inhibitors<br/>Male<br/>Mass Spectrometry<br/>Mice<br/>Pancreatic Neoplasms--diagnosis<br/>Paracrine Communication--drug effects<br/>Receptors, OSM-LIF--deficiency<br/>Tumor Microenvironment